BiomeMega

Australia · Research

BiomeMega is a cutting-edge Biotech startup that specialises in using deep tech (synbio, precision fermentation and bioengineering) to promote innovation for industry partners. Some of our applications include the obtaining of membrane-bound Omega 3, 7 & 9 as post-biotic ingredients for use in nutraceuticals, cellular cosmetics, and pharmaceuticals. We aim to transform the probiotic industry with a focus on human health, which can also be applied to improve animal diets while boosting supply sustainability with Australian provenance, enhancing the function of products in market, preventing diseases, and leveraging our microbiome R&D breakthroughs through collaboration with outstanding academic partners. Our expert team and partners are talented and passionate about what we do, and we envisage bringing to market a bank of sustainable ingredients, first-in-class pharmaceuticals, innovative nutraceuticals, and more outcomes that have started with the discovery and optimization of probiotics capable of producing Omega 7, Omega 9, and which contain both canonical and alternative Omega 3 pathways. As advocates for the transformative power of both pre, pro and post-biotics combined with the super nutrients, Omegas and membrane fragments, the team at BiomeMega have been sharing our passion for crafting the new natural while developing formulations and envisaging personalized ingredients that will help Australia reach and sustain our best potential. More exciting milestones to come.